DR Agarwals Health Care L
- ISIN
- INE943P01029
- Instrument key
- NSE_EQ|INE943P01029
as of 21/11/2026, 6:04:50 pm
- Open
- ₹549.60
- Day high
- ₹557.90
- Day low
- ₹547.55
- Prev. close
- ₹553.10
- Volume
- 86.1K
- VWAP
- ₹554.30
02/Price history
Price chart
6 months · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.
- Change · 6M
- +15.03%481.10 → 553.40
- Period high
- ₹571.9013/11/2026
- Period low
- ₹437.0016/6/2026
- From high
- -3.23%+26.64% from low
- Avg volume
- 6.01 L7.63 Cr total
- Volatility · ann.
- 26.1%127 candles · 65 up / 62 down
Candle data127 rows of open, high, low, close and volumeShowHide
| 20 Nov 2026 | 549.60 | 557.90 | 547.55 | 553.40 | +0.69% | 10.35 | 86.1K |
| 19 Nov 2026 | 550.30 | 558.50 | 544.70 | 553.10 | +0.51% | 13.80 | 1.89 L |
| 18 Nov 2026 | 535.00 | 555.00 | 535.00 | 549.50 | +2.71% | 20.00 | 1.33 L |
| 17 Nov 2026 | 550.70 | 552.95 | 538.05 | 539.95 | -1.95% | 14.90 | 1.02 L |
| 16 Nov 2026 | 555.00 | 556.05 | 543.05 | 550.70 | -0.77% | 13.00 | 79.9K |
| 13 Nov 2026 | 551.00 | 571.90 | 547.00 | 550.80 | -0.04% | 24.90 | 7.94 L |
| 12 Nov 2026 | 554.95 | 558.30 | 543.80 | 551.25 | -0.67% | 14.50 | 96.3K |
| 11 Nov 2026 | 541.90 | 559.00 | 531.20 | 554.15 | +2.26% | 27.80 | 4.72 L |
| 9 Nov 2026 | 519.70 | 539.80 | 509.20 | 537.30 | +3.39% | 30.60 | 2.77 L |
| 8 Nov 2026 | 519.65 | 520.60 | 512.80 | 514.60 | -0.97% | 7.80 | 11.9K |
Historical price and volume data · Showing 1–10 of 127
03/Valuation & returns
Key ratios vs sector
Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.
Price ÷ earnings per share
Worse than sector by 114%
Price ÷ book value per share
Worse than sector by 96%
Net income ÷ total assets
Worse than sector by 54%
Net income ÷ shareholders' equity
Worse than sector by 54%
EBIT ÷ capital employed
Worse than sector by 46%
Liquid assets ÷ current liabilities
Worse than sector by 62%
Enterprise value ÷ EBITDA
Worse than sector by 82%
04/Business
About the company
Sector: Healthcare
Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.
- ₹17,561 Cr
- $1.95B
reported in crore
reported in billion
Market capitalisation is reported at the sector-constituent level, not the standalone company level.
05/Profit & loss
Consolidated income statement
Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.
- Revenue · Sep 2026
- ₹665 Cr+7.22% vs Jun 2026
- Net profit · Sep 2026
- ₹57 Cr+3.33% vs Jun 2026
- Operating margin
- 12.0%was 12.1%
- Revenue CAGR · 4p
- 7.2%profit 9.2% · op 7.2%
| Revenue | 665 | 620 | 577 | 540 |
|---|---|---|---|---|
| Revenue growthreported | 7.2% | 7.6% | 6.7% | — |
| Operating profit | 80 | 75 | 77 | 65 |
| Operating profit growthreported | 6.3% | -1.9% | 18.3% | — |
| Operating marginderived | 12.0% | 12.1% | 13.3% | 12.0% |
| Net profit | 57 | 55 | 50 | 44 |
| Net profit growthreported | 3.3% | 10.1% | 14.5% | — |
| Net marginderived | 8.5% | 8.9% | 8.7% | 8.1% |
| EPS — basic₹/share, annual | — | — | 4.21 | — |
Figures in ₹ crore. Margin rows are computed from the reported values.
Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
| Revenue | 2,080 | 1,711 | 1,332 | 1,018 |
|---|---|---|---|---|
| Other Income | 44 | 46 | 44 | 14 |
| Total Revenue | 2,125 | 1,757 | 1,376 | 1,031 |
| Total Expenses | 1,877 | 1,594 | 1,236 | 948 |
| Profit Before Tax | 249 | 160 | 141 | 84 |
| Tax | 81 | 50 | 46 | -20 |
| Profit After Tax | 168 | 110 | 95 | 103 |
| EPS - Basic | 4.21 | 2.80 | 3.14 | 4.01 |
| EPS - Diluted | 4.18 | 2.78 | 3.13 | 4.00 |
This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.
06/Balance sheet
Consolidated balance sheet
Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.
- Total assets · Mar 2026
- ₹3,942 Cr+7.36% YoY
- Total liabilities
- ₹1,822 Cr
- Net worth
- ₹2,120 Cr
- Liabilities ÷ assets
- 46.2%lower means a lighter balance sheet
| Total assets | 3,942 | 3,672 | 2,753 | 1,825 |
|---|---|---|---|---|
| Total liabilities | 1,822 | 1,745 | 1,373 | 1,166 |
| Net worthderived | 2,120 | 1,927 | 1,380 | 659 |
| Liabilities ÷ assetsderived | 46.2% | 47.5% | 49.9% | 63.9% |
| Asset growthderived | 7.4% | 33.4% | 50.8% | — |
Figures in ₹ crore. Stacked chart height equals total assets.
Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
| Non-Current Assets | 3,369 | 2,883 | 1,994 | 1,515 |
|---|---|---|---|---|
| Current Assets | 573 | 789 | 759 | 310 |
| Total Assets | 3,942 | 3,672 | 2,753 | 1,825 |
| Current Liabilities | 461 | 478 | 400 | 301 |
| Net Current Asset | 111 | 311 | 359 | 9 |
| Non-Current Liabilities | 1,361 | 1,267 | 974 | 865 |
| Equity Capital | 2,120 | 1,927 | 1,380 | 659 |
| Total Equity & Liabilities | 3,942 | 3,672 | 2,753 | 1,825 |
Figures in ₹ crore unless the line item is per-share.
07/Cash flow
Consolidated cash flow
Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.
- Operating · Mar 2026
- ₹519 Cr+45.32% YoY
- Investing
- -₹308 Cr
- Financing
- -₹220 Cr
- Free cash flow
- ₹211 Croperating + investing
| Operating activities | 519 | 357 | 346 | 233 |
|---|---|---|---|---|
| Operating changereported | 45.3% | 3.2% | 48.4% | — |
| Investing activities | -308 | -750 | -914 | -509 |
| Investing changereported | 58.9% | 17.9% | -79.5% | — |
| Financing activities | -220 | 382 | 553 | 303 |
| Financing changereported | -157.7% | -30.9% | 82.2% | — |
| Net cash flowderived | -10 | -11 | -15 | 27 |
| Free cash flowoperating + investing | 211 | -393 | -568 | -276 |
Figures in ₹ crore.
Full annual line itemsProfit before tax through closing cash balanceShowHide
| Profit before tax | 249 | 160 | 141 | 84 |
|---|---|---|---|---|
| Income before WC changes | 622 | 491 | 373 | 281 |
| Change in Assets | -89 | -133 | -48 | -31 |
| Change in Liabilities | 41 | 35 | 52 | 19 |
| Change in WC | -48 | -98 | 5 | -13 |
| Cash flow from Operations | 519 | 357 | 346 | 233 |
| Cash flow from Investing | -308 | -750 | -914 | -509 |
| Cash flow from Financing | -220 | 382 | 553 | 303 |
| Total Cash Flow | -10 | -11 | -15 | 27 |
| Cash (Start of the year) | 100 | 112 | 127 | 100 |
| Cash (End of the year) | 91 | 100 | 112 | 127 |
Figures in ₹ crore unless the line item is per-share.
09/Events
Corporate actions
Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.
No corporate actions on record
10/Comparison
Peers & competitors
Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.
| APOLLOHOSPApollo Hospitals Enter. L | Healthcare Services | ₹9,200.00 | +5.29% | 14.13 L | ₹1,32,139 Cr | $14.68B | |
| MAXHEALTHMAX Healthcare INS Ltd | Healthcare Services | ₹1,081.00 | +3.88% | 95.32 L | ₹1,05,080 Cr | $11.68B | |
| MANIPALHOSManipal Health Enterpri L | Healthcare | ₹702.20 | +0.83% | 11.62 L | ₹92,366 Cr | $10.26B | |
| ASTERDMAster DM Quality Care Ltd | Healthcare Services | ₹779.30 | +5.41% | 26.66 L | ₹67,960 Cr | $7.55B | |
| FORTISFortis Healthcare Ltd | Healthcare Services | ₹825.00 | +1.87% | 22.88 L | ₹62,284 Cr | $6.92B | |
| MEDANTAGlobal Health Limited | Healthcare Services | ₹1,480.20 | +0.13% | 2.65 L | ₹39,829 Cr | $4.43B | |
| NHNarayana Hrudayalaya Ltd. | Healthcare Services | ₹1,945.00 | +3.84% | 7.85 L | ₹39,757 Cr | $4.42B | |
| LALPATHLABDR. LAL Path Labs Ltd. | Healthcare Services | ₹1,989.00 | +1.31% | 2.65 L | ₹33,680 Cr | $3.74B | |
| KIMSKrishna Inst Of MED SCI L | Healthcare Services | ₹795.60 | +3.62% | 10.44 L | ₹33,483 Cr | $3.72B | |
| SYNGENESyngene International Ltd | Diversified | ₹451.70 | +3.28% | 25.58 L | ₹18,240 Cr | $2.03B |
Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10
11/Coverage
Company news
Articles published in the last seven days, paginated by the provider.
No news in the last seven days
Company news is available for a rolling one-week window.